公开(公告)号：US11576961B2

公开(公告)日：2023-02-14

申请号：US16493986

申请日：2018-03-15

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Eric Yi-Chun Huang ,  Kerim Babaoglu ,  Jessica Anne Flynn ,  Lan Zhang ,  David Nickle

IPC: A61K39/145 ,  A61K39/00

Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccine. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.

公开(公告)号：US20210187097A1

公开(公告)日：2021-06-24

申请号：US16493986

申请日：2018-03-15

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Eric Yi-Chun Huang ,  Kerim Babaoglu ,  Jessica Anne Flynn ,  Lan Zhang ,  David Nickle

IPC: A61K39/145

Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccine. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.

公开(公告)号：US20220080038A9

公开(公告)日：2022-03-17

申请号：US16493986

申请日：2018-03-15

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Eric Yi-Chun Huang ,  Kerim Babaoglu ,  Jessica Anne Flynn ,  Lan Zhang ,  David Nickle

IPC: A61K39/145

Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccine. In a preferred embodiment, the vaccine is formulated as a lipid nanoparticle comprising at least one cationic lipid.

公开(公告)号：US20230310576A1

公开(公告)日：2023-10-05

申请号：US18055193

申请日：2022-11-14

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Eric Yi-Chun Huang ,  Kerim Babaoglu ,  Jessica Anne Flynn ,  Lan Zhang ,  David Nickle

IPC: A61K39/145

CPC classification number: A61K39/145 ,  A61K2039/5252

Abstract: The disclosure relates to broad spectrum influenza virus ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.